Filing Details

Accession Number:
0001209191-20-046095
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-11 16:03:56
Reporting Period:
2020-08-10
Accepted Time:
2020-08-11 16:03:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1720725 Oyster Point Pharma Inc. OYST Biological Products, (No Disgnostic Substances) (2836) 811030955
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1783264 John Snisarenko C/O Oyster Point Pharma, Inc.
202 Carnegie Center, Suite 109
Princeton NJ 08540
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-10 4,000 $25.97 7,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct